Description
Join us for a National Grand Round on Life Care Planning for Physiatrists, where we explore the critical role of rehabilitation physicians in developing comprehensive, evidence-based care plans for individuals with complex medical needs. This session will cover key principles, real-world applications, and the physiatrist’s unique contribution to interdisciplinary planning for long-term patient outcomes. Gain valuable insights from experts in the field and enhance your ability to navigate life care planning in clinical and medicolegal settings.
Faculty
David Haustein, MD, MBA, FAAPMR
Joe G. Gonzales, MD, FAAPMR
Charlotte H. Smith, MD , FAAPMR
Learning Objectives
Upon completion of this activity, participants will be able to:
- Recognize topics of broad or in-depth focus that physiatrists of all specializations need to apply to their practice
- Discuss the latest evidence, research and best practices within the physical medicine and rehabilitation (PM&R) field
- Define and use current techniques, procedures and research to improve physician practice and quality of patient care
Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Financial Disclosures
AAPM&R requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest, which is any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to control content and their disclosed financial relationships are listed below.
AAPM&R Medical Education Committee
Rachel A. Brakke Holman, MD: Disclosed no relevant financial relationships.
Sarah M. Eickmeyer, MD: Disclosed no relevant financial relationships.
Chelsea D. Frost, MD, MS: Disclosed no relevant financial relationships.
Theresa A. Gillis, MD: Disclosed no relevant financial relationships.
Kevin N. Hakimi, MD: Disclosed no relevant financial relationships.
Rita G. Hamilton, DO: Disclosed no relevant financial relationships.
Sarah K. Hwang, MD: Disclosed no relevant financial relationships.
Monica E. Rho, MD: Disclosed no relevant financial relationships.
Jennifer A. Soo Hoo, MD: Disclosed no relevant financial relationships.
Brionn K. Tonkin, MD: Disclosed no relevant financial relationships.
Stephanie Tow, MD: Disclosed no relevant financial relationships.
Justin L. Weppner, DO: Disclosed no relevant financial relationships.
Ricardo J. Fuentes-Saavedra, MD: Disclosed no relevant financial relationships.
Jeremy Roberts, MD: Disclosed no relevant financial relationships.
AAPM&R CME Committee
Brionn K. Tonkin, MD: Disclosed no relevant financial relationships.
Leah G. Concannon, MD: Disclosed no relevant financial relationships.
Cherry C. Junn, MD: Disclosed no relevant financial relationships.
Tracy M. Paul, MD: Disclosed no relevant financial relationships.
Cynthia G. Pineda, MD: Disclosed no relevant financial relationships.
Jeremy Roberts, MD: Disclosed no relevant financial relationships.
Peter C. Yeh, MD: Disclosed no relevant financial relationships.
No other planners, faculty or other individuals in control of content disclosed any relevant financial relationships.
FDA Disclosures
All faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.